Health
Study finds significant variation in biomarker test utilization and treatment for non–small-cell lung cancer – News-Medical.Net
Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis…
Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis of non-small-cell lung cancer (NSCLC). In a new study in TheJournal of Molecular Diagnosis, published by Elsevier, investigators provide for the first time a complete overview of biomarker testing, spanning multiple treatment lines, in a single cohort of patients.
Using exploratory data analysis and process-mining techniques in a real-world…
-
Business13 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
Noosa News24 hours agoQueensland’s bid for net zero by 2050 unlikely under new energy plan: expert
-
General10 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
General22 hours agoWestern Bulldogs extend Essendon’s losing streak with 57 point thrashing